Detection of anti-lipopolysaccharide antibodies to Vibrio cholerae O1 and O139 using a novel microtiter limulus amebocyte lysate (LAL) assay

Clinica Chimica Acta

Volumn 312, Issue 1-2, 2001, Pages 49-54

  Chang, H Sunny ^a,b   Sack, David A ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b NONE   (United States)

Author keywords

Antibody assay; Cholera; Horseshoe crab; Limulus amebocyte lysate; Vibriocidal

Indexed keywords

BACTERIUM ANTIBODY; BACTERIUM LIPOPOLYSACCHARIDE; CHOLERA VACCINE; REAGENT; UNCLASSIFIED DRUG; VIBRIO CHOLERAE ANTIBODY;

ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CHOLERA; CONTROLLED STUDY; ESCHERICHIA COLI; GEL; HUMAN; LIMULUS LYSATE TEST; NONHUMAN; PRIORITY JOURNAL; SEROTYPE; VIBRIO CHOLERAE;

ANIMALS; ANTIBODIES, BACTERIAL; HUMANS; LIMULUS TEST; LIPOPOLYSACCHARIDES; RABBITS; SENSITIVITY AND SPECIFICITY; SPECIES SPECIFICITY; VIBRIO CHOLERAE;

DECAPODA (CRUSTACEA); LIMULUS; MEROSTOMATA; VIBRIO CHOLERAE;

EID: 0034814067     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(01)00588-5     Document Type: Article

References (13)

1. Immunity of cholera in man: Relative role of antibacterial versus antitoxic immunity
2. Analysis of the roles of antilipopolysaccharide and anti-cholera toxin immunoglobulin A (IgA) antibodies in protection against Vibrio cholerae and cholera toxin by use of monoclonal IgA antibodies in vivo
3. Intestinal immunity and vaccine development: A WHO memorandum
4. Mucosal antitoxic and antibacterial immunity after cholera disease and after immunization with a combined B subunit-whole cell vaccine
5. Clinical and immunologic characteristics of Vibrio cholerae O139 Bengal infection in North American volunteers
6. Detection of NAD:arginine ADPribosyltransferases in animal tissues using 125I-labeled 1-(p-hydroxyphenyl) 2-guanidinoethane as ADPribose acceptor
7. Enterotoxigenic Escherichia coli and Reovirus-like agent in rural Bangladesh
8. Detection by immune electron microscopy of 27-nm viral particles associated with community-acquired diarrhea in children
9. Peru-15, an improved live attenuated oral vaccine candidate for Vibrio cholerae O1
10. New attenuated derivatives of Vibrio cholerae
11. Antibody responses after immunization with killed oral cholera vaccines during the 1985 vaccine field trial in Bangladesh
12. Measurement of transcriptional activity in pathogenic bacteria recovered directly from infected host tissue